Truist Securities Reiterates Buy on argenx, Raises Price Target to $700
ARGXJanuary 14, 2025
Read more →JMP Securities Maintains Market Outperform on argenx, Raises Price Target to $696
ARGXJanuary 14, 2025
Read more →argenx Preliminary 2024 Financial Results: $2.2B In Annual Product Sales, $737M In Q4 Revenue, And $3.4B In Cash Reserves
ARGXJanuary 13, 2025
Read more →Wells Fargo Maintains Overweight on argenx, Raises Price Target to $723
ARGXDecember 19, 2024
Read more →HC Wainwright & Co. Reiterates Buy on argenx, Maintains $617 Price Target
ARGXNovember 20, 2024
Read more →argenx Pushes Efgartigimod SC Forward: Phase 2 Data Support Continued Development In Debilitating Myositis Conditions
ARGXNovember 20, 2024
Read more →(ARGX) - Analyzing argenx's Short Interest
ARGXNovember 14, 2024
Read more →Peering Into argenx's Recent Short Interest
ARGXNovember 6, 2024
Read more →This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
ARGXNovember 5, 2024
Read more →Scotiabank Upgrades argenx to Sector Outperform, Raises Price Target to $715
ARGXNovember 5, 2024
Read more →JP Morgan Maintains Overweight on argenx, Raises Price Target to $670
ARGXNovember 4, 2024
Read more →Guggenheim Maintains Buy on argenx, Raises Price Target to $665
ARGXNovember 1, 2024
Read more →Wells Fargo Maintains Overweight on argenx, Raises Price Target to $639
ARGXNovember 1, 2024
Read more →Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'
ARGXArgenx SE ADR shares jumped after impressive earnings. Analysts raised price targets and noted strong pipeline and global expansion.
November 1, 2024
Read more →This Atlassian Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
ARGXNovember 1, 2024
Read more →This Huntington Ingalls Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
ARGXNovember 1, 2024
Read more →Truist Securities Maintains Buy on argenx, Raises Price Target to $660
ARGXNovember 1, 2024
Read more →Piper Sandler Maintains Overweight on argenx, Raises Price Target to $620
ARGXNovember 1, 2024
Read more →Oppenheimer Maintains Outperform on argenx, Raises Price Target to $646
ARGXNovember 1, 2024
Read more →JMP Securities Maintains Market Outperform on argenx, Raises Price Target to $606
ARGXNovember 1, 2024
Read more →William Blair Upgrades argenx to Outperform
ARGXNovember 1, 2024
Read more →HC Wainwright & Co. Maintains Buy on argenx, Raises Price Target to $617
ARGXNovember 1, 2024
Read more →Baird Downgrades argenx to Neutral, Raises Price Target to $650
ARGXNovember 1, 2024
Read more →Truist Securities Maintains Buy on argenx, Raises Price Target to $660
ARGXOctober 31, 2024
Read more →argenx Q3 2024 GAAP EPS $1.39 Beats $0.02 Estimate, Sales $588.878M Beat $538.520M Estimate
ARGXOctober 31, 2024
Read more →Morgan Stanley Upgrades argenx to Overweight, Announces $375 Price Target
ARGXMay 3, 2022
Read more →